Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06234605
Title A Study of HC-7366 in Combination With Belzutifan (WELIRE) in Patients With Renal Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors HiberCell, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Cancer Center RECRUITING Tucson Arizona 85719 United States Details
University of California San Diego Moores Cancer Center RECRUITING La Jolla California 92093 United States Details
Cedars-Sinai Medical Center RECRUITING Los Angeles California 90048 United States Details
Rocky Mountain Cancer Centers, LLP RECRUITING Lone Tree Colorado 80124 United States Details
HealthPartners Cancer Research Center RECRUITING Saint Paul Minnesota 55101 United States Details
Washington University School of Medicine RECRUITING Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
University Hospitals Cleveland Medical Center RECRUITING Cleveland Ohio 44106 United States Details
Cleveland Clinic RECRUITING Cleveland Ohio 44195 United States Details
Providence Cancer Institute RECRUITING Portland Oregon 97213 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
Texas Oncology RECRUITING Dallas Texas 75246 United States Details
Virginia Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
Swedish Medical Center RECRUITING Seattle Washington 98104 United States Details
University of Wisconsin - Carbone Cancer Center RECRUITING Madison Wisconsin 53705 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field